AgeX Therapeutics, Inc.
- Jurisdiction
United States - ISIN
US00848H1086 (AGE )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
4
/ 9
Profile
AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. Read full profile
Stock price
Fundamentals
- Net revenue
€79.79K - Gross margin
-43.0% - EBIT
-€21.92M - EBIT margin
-27,468.8% - Net income
-€2.31M - Net margin
-2,901.1%
Statement period: - (published )
Dividends
No dividend payouts
Insider Transactions
Name | Title | Transaction Date | Shares | Price | Value |
---|---|---|---|---|---|
Moreadith Randall | Chief Scientific Officer |
|
|
|
|
Moreadith Randall | Chief Scientific Officer |
|
|
|
|
Moreadith Randall | Chief Scientific Officer |
|
|
|
|
Moreadith Randall | Chief Scientific Officer |
|
|
|
|
Moreadith Randall | Chief Scientific Officer |
|
|
|
|